Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Opinion Article
This is a selection made from among articles on Drug Treatment Opinion. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug Addiction Rehab
from:Have you ever thought about what drug addiction rehab really means? The words are thrown around in the media, in government, and in our schools, but what exactly is rehab for drug addiction?
In its simplest form, drug addiction rehab means quitting drugs and learning how to live a drug-free life. However, it’s much, much more than just quitting drugs. Various drugs have different effects on the body and mind just as certain people are prone to addiction to certain drugs. Treatment can vary according to which drug is involved as well.
Drug addiction rehab can take the form of behavioral, or cognitive, therapy, medication, or a combination of both. It depends on a lot of factors that will determine which treatment will work best.
Behavioral therapy offers addicts strategies to coping with their drug cravings. It teaches them ways to avoid drugs and prevent relapse. This type of therapy also teaches them how to deal with relapse should it occur.
When a person's drug-related behavior places him or her at higher risk for AIDS or other infectious diseases, behavioral therapies can help to reduce the risk of disease transmission. Case management and referral to other medical, psychological, and social services are crucial components of treatment for many patients.
The best programs provide a combination of therapies and other services to meet the needs of the individual patient, which are shaped by such issues as age, race, culture, sexual orientation, gender, pregnancy, parenting, housing, and employment, as well as physical and sexual abuse.
Treatment medications, such as methadone, LAAM, and naltrexone, are available for individuals addicted to opiates. Nicotine preparations (patches, gum, nasal spray) and bupropion are available for individuals addicted to nicotine.
Medications, such as antidepressants, mood stabilizers, or neuroleptics, may be critical for treatment success when patients have co-occurring mental disorders, such as depression, anxiety disorder, bipolar disorder, or psychosis.
Drug addiction rehab can occur in a variety of settings, in many different forms, and for different lengths of time. Because drug addiction is typically a chronic disorder characterized by occasional relapses, a short-term, one-time treatment often is not sufficient. For many, rehab is a long-term process that involves multiple interventions and attempts at abstinence.
Rehab is probably the best course of action when trying to beat an addiction. It doesn’t have to take place at an in-patient facility, but it does offer the best success rate when it comes to beating drug addiction and leading a drug-free life.
Drug Treatment Opinion Specific links
Drug Treatment Opinion News
Eisai Receives Positive CHMP Opinion for Zonegran® (Zonisamide) Monotherapy ... - Einnews Portugal
Eisai Receives Positive CHMP Opinion for Zonegran® (Zonisamide) Monotherapy ... Einnews Portugal Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for extending the use of once-daily Zonegran ® (zonisamide) as monotherapy for the treatment of partial ... |
Amber Portwood 'Needs Help,' Says Expert - Hollywood Life
 New York Daily News | Amber Portwood 'Needs Help,' Says Expert Hollywood Life We're still baffled by Amber Portwood's decision to rot behind bars instead of undergoing drug treatment for her addiction issues. However, an expert explains the worst is still yet to come for the former Teen Mom star. “In my opinion Amber is an ... Amber Portwood Hasn't 'Hit Rock Bottom Yet,' Says Expert |
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor ... - MarketWatch (press release)
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor ... MarketWatch (press release) KALYDECO(TM) (ivacaftor) is the first treatment to target the underlying cause of CF. KALYDECO (150mg, q12h) was approved by the US Food and Drug Administration in January 2012 for use in people with CF ages 6 and older who have at least one copy of ... |
Vertex Pharma receives European recommendation for approval of cystic fibrosis ... - Proactive Investors USA & Canada
 Proactive Investors USA & Canada | Vertex Pharma receives European recommendation for approval of cystic fibrosis ... Proactive Investors USA & Canada The company said the medicine is the first to treat the underlying cause of the disease. Vertex is a medicinal company focused on discovering, developing, and producing small molecule drugs for the treatment of serious diseases. |
Business Forum: Region's life sciences industry needs PDUFA to remain vibrant - Pittsburgh Post Gazette
Business Forum: Region's life sciences industry needs PDUFA to remain vibrant Pittsburgh Post Gazette It is now up to the House of Representatives to seal the deal that will ensure an improved, enhanced drug review process; promote development of innovative therapies; speed new medicines to patients; and give the Food and Drug Administration the tools ... |
Dr. Donohue: Spinal cord inflammation paralyzes the legs - Herald & Review
Dr. Donohue: Spinal cord inflammation paralyzes the legs Herald & Review The optimum treatment hasn't been determined. Large doses of the cortisone drug prednisone often are used in an attempt to quiet the inflammation. Other therapies also have been employed, but none has become the treatment of choice. |
Politics in the Diagnosis of Addiction - Huffington Post (blog)
 StudentNews.ie | Politics in the Diagnosis of Addiction Huffington Post (blog) The New York Times' Ian Urbina -- who was previously known for his work on fracking -- has cast his eye on the politics and economics of the redefinition of addiction currently taking place in the revision of the psychiatric "bible," the Diagnostic and ... Medical 'bible' squabble |
Roche Drugs To Be Key Focus At Upcoming US Cancer Meeting ASCO - Wall Street Journal
Roche Drugs To Be Key Focus At Upcoming US Cancer Meeting ASCO Wall Street Journal T-DM1, a potential 'blockbuster' therapy generating more than $1 billion in annual sales, is an antibody drug which delivers the chemotherapy agent directly inside cancer cells, with the aim of causing fewer side effects and possibly increasing ... |
Opinion: For Mental Health Month, a tribute to the power of mental health care - The Star-Ledger - NJ.com
 The Star-Ledger - NJ.com | Opinion: For Mental Health Month, a tribute to the power of mental health care The Star-Ledger - NJ.com By Times of Trenton guest opinion column By Shauna Moses Over the past six years, since I joined the New Jersey Association of Mental Health and Addiction Agencies (NJAMHAA), I have been greatly inspired by many stories of how the services our members ... |
FDA Regulation of Antibiotic Use in Agricultural Animals - JURIST
 JURIST | FDA Regulation of Antibiotic Use in Agricultural Animals JURIST The opinion itself is rather curious and arguably misunderstands the Federal Food, Drug and Cosmetic Act's (FDCA) requirements for withdrawal of drug approvals and its overall approach to risk assessment. Nonetheless, it may serve as a useful spur to ... |